Botanical species · safety record

Melilotus albus

The EFSA Compendium of Botanicals holds 8 constituent measurements for Melilotus albus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melilotus albus Medik.

8Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Coumarins3
  • Coumarin1
  • P-coumaric acid1
  • Pentacyclic triterpene saponins1
  • Saponins1
  • Triterpene saponins1

Plant parts

  • Roots and other underground parts3
  • Leaves2
  • Seed2
  • Shoot1

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
SaponinsRoots and other underground partsSolvent extraction—UnspecifiedResolve DOI
CoumarinSeedSolvent extraction3 PercentUnspecifiedNo resolvable identifier
CoumarinsRoots and other underground partsSolvent extraction—Chromatographic testsNo resolvable identifier
CoumarinsShootSolvent extraction—Chromatographic testsNo resolvable identifier
CoumarinsLeavesSolvent extraction—UV/VIS spectroscopy (photometry)No resolvable identifier
P-coumaric acidLeavesSolvent extraction—UnspecifiedNo resolvable identifier
Pentacyclic triterpene saponinsRoots and other underground partsSolvent extraction——No resolvable identifier
Triterpene saponinsSeedSolvent extraction—UnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Khodakov, GV., Akimov, YA., Shashkov, AS., Kintia, PK., Grishkovets, VI., Waller, GR., Yamasaki, K. Triterpene and steroid saponins isolated from two melilotus species. Saponins used in food and agriculture, 1996, vol. 405, p. 211-222.
  2. Reppel, L., Wagenbreth, D. Investigations on the content of coumarins and related substances in grafts between Melilotus albus and Trigonella foenum-graecum. Flora (jena, 1818-1965), 1958, p. 212-227.
  3. Kahnt, Guenter., Schoen, Walter J. Determination of coumarin and glucosides of cournaric acid in Melilotus albus leaves. Angewandte botanik, 1962, p. 33-49.
  4. Funck, E. �ber das Vorkommen und den Nachweis eines Saponins in Melilotus albus. Mikrochemie, 1938, vol. 24, no. 1, p. 262-264. DOI
  5. Blaim, Kazimierz., Przeszlakowska, M. Glycosides of Melilotus albus seeds. Roczniki nauk rolniczych, seria a: produkcja roslinna, 1969, p. 75-81.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue